Wells Fargo’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,544
| Closed | -$838K | – | 7619 |
|
|
2022
Q3 | $838K | Sell |
5,544
-2,805
| -34% | -$424K | ﹤0.01% | 3139 |
|
|
2022
Q2 | $1.22M | Sell |
8,349
-71,523
| -90% | -$10.4M | ﹤0.01% | 2983 |
|
|
2022
Q1 | $9.47M | Sell |
79,872
-21,636
| -21% | -$2.56M | ﹤0.01% | 1798 |
|
|
2021
Q4 | $14M | Sell |
101,508
-1,675,910
| -94% | -$231M | ﹤0.01% | 1528 |
|
|
2021
Q3 | $247M | Buy |
1,777,418
+346,231
| +24% | +$48.1M | 0.05% | 335 |
|
|
2021
Q2 | $139M | Buy |
1,431,187
+295,977
| +26% | +$28.7M | 0.03% | 515 |
|
|
2021
Q1 | $77.6M | Buy |
1,135,210
+137,173
| +14% | +$9.38M | 0.02% | 792 |
|
|
2020
Q4 | $85.5M | Sell |
998,037
-67,086
| -6% | -$5.75M | 0.02% | 709 |
|
|
2020
Q3 | $69.2M | Buy |
1,065,123
+179,306
| +20% | +$11.7M | 0.02% | 710 |
|
|
2020
Q2 | $64.8M | Buy |
885,817
+546,031
| +161% | +$39.9M | 0.02% | 729 |
|
|
2020
Q1 | $11.6M | Buy |
339,786
+306,285
| +914% | +$10.4M | ﹤0.01% | 1557 |
|
|
2019
Q4 | $1.82M | Sell |
33,501
-5,669
| -14% | -$309K | ﹤0.01% | 3381 |
|
|
2019
Q3 | $1.63M | Buy |
39,170
+5,995
| +18% | +$250K | ﹤0.01% | 3448 |
|
|
2019
Q2 | $1.45M | Sell |
33,175
-2,990
| -8% | -$131K | ﹤0.01% | 3553 |
|
|
2019
Q1 | $1.86M | Sell |
36,165
-3,809
| -10% | -$196K | ﹤0.01% | 3392 |
|
|
2018
Q4 | $1.48M | Buy |
39,974
+1,439
| +4% | +$53.2K | ﹤0.01% | 3474 |
|
|
2018
Q3 | $1.45M | Buy |
38,535
+807
| +2% | +$30.3K | ﹤0.01% | 3627 |
|
|
2018
Q2 | $1.49M | Sell |
37,728
-3,456
| -8% | -$137K | ﹤0.01% | 3642 |
|
|
2018
Q1 | $1.06M | Buy |
41,184
+11,373
| +38% | +$293K | ﹤0.01% | 3808 |
|
|
2017
Q4 | $805K | Sell |
29,811
-5,996
| -17% | -$162K | ﹤0.01% | 3994 |
|
|
2017
Q3 | $1.34M | Buy |
35,807
+9,594
| +37% | +$359K | ﹤0.01% | 3577 |
|
|
2017
Q2 | $655K | Buy |
+26,213
| New | +$655K | ﹤0.01% | 3958 |
|